Mesa Laboratories, Inc.

Informe acción NasdaqGS:MLAB

Capitalización de mercado: US$592.5m

Salud financiera de hoja de balance de Mesa Laboratories

Salud financiera controles de criterios 2/6

Mesa Laboratories tiene un patrimonio de accionistas total de $161.5M y una deuda total de $205.0M, lo que sitúa su ratio deuda-patrimonio en 127%. Sus activos y pasivos totales son $454.1M y $292.6M respectivamente. El BAIT de Mesa Laboratories es de $14.7M, por lo que su ratio de cobertura de intereses es de 1.5. Tiene efectivo e inversiones a corto plazo que ascienden a $26.0M.

Información clave

127.0%

Ratio deuda-patrimonio

US$204.98m

Deuda

Ratio de cobertura de intereses1.5x
EfectivoUS$26.00m
PatrimonioUS$161.45m
Total pasivoUS$292.65m
Activos totalesUS$454.10m

Actualizaciones recientes sobre salud financiera

Recent updates

Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

Nov 20
Investors Give Mesa Laboratories, Inc. (NASDAQ:MLAB) Shares A 25% Hiding

We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

Oct 17
We Think Mesa Laboratories (NASDAQ:MLAB) Can Stay On Top Of Its Debt

A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Jul 29
A Piece Of The Puzzle Missing From Mesa Laboratories, Inc.'s (NASDAQ:MLAB) 27% Share Price Climb

Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

May 03
Is Now An Opportune Moment To Examine Mesa Laboratories, Inc. (NASDAQ:MLAB)?

Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mar 15
Is Mesa Laboratories (NASDAQ:MLAB) Using Too Much Debt?

Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Feb 08
Mesa Laboratories, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next

Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Dec 05
Is Mesa Laboratories, Inc. (NASDAQ:MLAB) Trading At A 43% Discount?

Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Sep 28
Is Mesa Laboratories (NASDAQ:MLAB) A Risky Investment?

Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Aug 09
Estimating The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Jun 28
We Think Mesa Laboratories (NASDAQ:MLAB) Is Taking Some Risk With Its Debt

Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

May 31
Investor Optimism Abounds Mesa Laboratories, Inc. (NASDAQ:MLAB) But Growth Is Lacking

A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Apr 12
A Look At The Intrinsic Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mar 13
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Dec 20
Estimating The Fair Value Of Mesa Laboratories, Inc. (NASDAQ:MLAB)

Mesa Laboratories declares $0.16 dividend

Oct 03

Mesa Laboratories: Softening Bottom Line Fundamentals, Fairly Priced

Sep 09

Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?

Sep 06
Are Investors Undervaluing Mesa Laboratories, Inc. (NASDAQ:MLAB) By 41%?

Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Aug 08
Does Mesa Laboratories (NASDAQ:MLAB) Have A Healthy Balance Sheet?

Mesa Laboratories GAAP EPS of -$0.27 misses by $0.27, revenue of $50.45M misses by $1.72M

Aug 04

Mesa Laboratories declares $0.16 dividend

Jul 07

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo ($108.0M) de MLAB no cubren sus pasivos a corto plazo ($153.2M).

Pasivo a largo plazo: Los activos a corto plazo ($108.0M) de MLAB no cubren sus pasivos a largo plazo ($139.4M).


Historial y análisis de deuda-patrimonio

Nivel de deuda: La relación deuda neta-capital de MLAB (110.9%) se considera alta.

Reducción de la deuda: El ratio deuda-patrimonio de MLAB ha crecido de 60.1% a 127% en los últimos 5 años.


Hoja de balance


Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: Aunque no es rentable MLAB tiene suficiente cash runway para más de 3 años si mantiene su actual nivel positivo de flujo de caja libre.

Pronóstico de cash runway: MLAB no es rentable pero tiene suficiente cash runway para más de 3 años, debido a que el flujo de caja libre es positivo y crece un 5.7% al año.


Descubre empresas con salud financiera